VA awards new contract for debunked PTSD drug

The Veterans Affairs Department continues to issue contracts to purchase an anti-psychotic drug to treat post-traumatic stress disorder despite research showing the drug, risperidone, is no more effective than a placebo.

Read the full story on Nextgov.com.